KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to 0.56.

  • Dynavax Technologies' Equity Ratio fell 1205.09% to 0.56 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.56, marking a year-over-year decrease of 1205.09%. This contributed to the annual value of 0.61 for FY2024, which is 300.83% down from last year.
  • Per Dynavax Technologies' latest filing, its Equity Ratio stood at 0.56 for Q3 2025, which was down 1205.09% from 0.54 recorded in Q2 2025.
  • In the past 5 years, Dynavax Technologies' Equity Ratio registered a high of 0.64 during Q3 2024, and its lowest value of 0.07 during Q3 2021.
  • Moreover, its 5-year median value for Equity Ratio was 0.56 (2025), whereas its average is 0.47.
  • In the last 5 years, Dynavax Technologies' Equity Ratio crashed by 6252.27% in 2021 and then surged by 58173.71% in 2022.
  • Quarter analysis of 5 years shows Dynavax Technologies' Equity Ratio stood at 0.21 in 2021, then soared by 175.43% to 0.59 in 2022, then rose by 5.86% to 0.62 in 2023, then dropped by 3.01% to 0.61 in 2024, then dropped by 6.74% to 0.56 in 2025.
  • Its Equity Ratio was 0.56 in Q3 2025, compared to 0.54 in Q2 2025 and 0.56 in Q1 2025.